AML 8227 is an aggressive, relapsed leukemia sample with mutations in p53, RUNX1 and FLT3-ITD that maintains a phenotypic and functional LSC hierarchy in culture and can be grown indefinitely (see ref.23 and K. Eppert, unpublished data). Here, FLT3 is linked to leukemia.